|Articles|June 1, 2018
- Pharmaceutical Executive-06-01-2018
- Volume 38
- Issue 6
Pharmaceutical Executive, June 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive June 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
US Maps Strategy to Reform Drug Pricingalmost 8 years ago
C-Suite Personality: Fit for Future?almost 8 years ago
Insights for the Winalmost 8 years ago
Leveraging Lab Data in Advent of Personalized Marketingalmost 8 years ago
Asembia 2018: User-Friendly Urgencyalmost 8 years ago
Piecing Together the Pricing Puzzle: The Midterm Electionsalmost 8 years ago
Pharm Exec's Top 50 Companies 2018Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5